News
Prescription drug pricing reform must rein in pharmacy benefit managers
U.S. sues Cigna Corp for overcharging Medicare Advantage program
Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, & Providers: A 2022 Update
Opinion: Reforms will lower prescription drug costs for patients and taxpayers
Medicare Advantage gets exploited by insurers
PBM Accountability Project Managing Director Mark Blum Joins Pharmacy Podcast Network
War over drug-cost assistance traps sickest patients in the middle
FTC examining options for PBM regulation
Antitrust regulator takes aim at drug middlemen
Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims
Time to Rein in the Drug-Industry Middlemen Exploiting Patients
The Middleman Mentality Is Killing American Medicine
Consolidation in US health care negatively impacts cancer care
Centene agrees to pay Texas $166 million in Medicaid drug pricing settlement
Patient groups sue HHS over co-pay assistance program
Pharmacy Middlemen Deserve Reformers' Attention
Centene to pay $33.3 mln to settle Washington Medicaid fraud claims
From Meat to Insulin, How the Middlemen Economy Makes Everything More Expensive
Frustrated pharmacists are opting out of the insurance system, saving some customers hundreds...
Charting a Course to Protect Consumers at Pharmacy Counters
Fixing the PBM Problem Is the Silver Bullet for Lowering Drug Costs in America
How the failure to cap insulin prices impacts Latinos
Is your health plan covering the lowest-cost drugs?
The Democrats' Deal Only Targets One Piece of Our Drug-Pricing Problem